Phreesia, Inc. (PHR)

$22.62

-0.54

(-2.33%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Phreesia, Inc.

  • Increasing Revenue

    Revenue is up for the last 17 quarters, 32.81M → 95.00M (in $), with an average increase of 6.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 8 quarters, -51.24M → -30.64M (in $), with an average increase of 7.8% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 65.3%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 12.5% return, outperforming this stock by 67.2%

Performance

  • $22.56
    $23.35
    $22.62
    downward going graph

    0.27%

    Downside

    Day's Volatility :3.38%

    Upside

    3.13%

    downward going graph
  • $12.05
    $34.98
    $22.62
    downward going graph

    46.73%

    Downside

    52 Weeks Volatility :65.55%

    Upside

    35.33%

    downward going graph

Returns

PeriodPhreesia, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-6.65%
-0.7%
0.0%
6 Months
47.61%
6.6%
0.0%
1 Year
-28.32%
3.7%
-1.5%
3 Years
-53.14%
14.0%
-21.8%

Highlights

Market Capitalization
1.3B
Book Value
$4.46
Earnings Per Share (EPS)
-2.51
Wall Street Target Price
30.13
Profit Margin
-38.42%
Operating Margin TTM
-46.68%
Return On Assets TTM
-22.25%
Return On Equity TTM
-50.77%
Revenue TTM
356.3M
Revenue Per Share TTM
6.53
Quarterly Revenue Growth YOY
45.7%
Gross Profit TTM
171.6M
EBITDA
-111.8M
Diluted Eps TTM
-2.51
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.23
EPS Estimate Next Year
-0.36
EPS Estimate Current Quarter
-0.26
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    84%Buy
    15%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Phreesia, Inc.(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
17
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 33.2%

Current $22.62
Target $30.13

Company Financials

FY19Y/Y Change
Revenue
99.9M
↑ 25.12%
Net Income
-15.1M
↓ 17.21%
Net Profit Margin
-15.08%
↑ 7.71%
FY20Y/Y Change
Revenue
124.8M
↑ 24.92%
Net Income
-20.3M
↑ 34.73%
Net Profit Margin
-16.26%
↓ 1.18%
FY21Y/Y Change
Revenue
148.7M
↑ 19.15%
Net Income
-27.3M
↑ 34.49%
Net Profit Margin
-18.36%
↓ 2.1%
FY22Y/Y Change
Revenue
213.2M
↑ 43.42%
Net Income
-118.2M
↑ 332.95%
Net Profit Margin
-55.41%
↓ 37.05%
FY23Y/Y Change
Revenue
280.9M
↑ 31.74%
Net Income
-176.1M
↑ 49.07%
Net Profit Margin
-62.71%
↓ 7.3%
FY24Y/Y Change
Revenue
356.3M
↑ 26.84%
Net Income
-136.9M
↓ 22.29%
Net Profit Margin
-38.42%
↑ 24.29%
Q4 FY22Q/Q Change
Revenue
73.1M
↑ 7.72%
Net Income
-40.2M
↓ 14.02%
Net Profit Margin
-54.95%
↑ 13.88%
Q1 FY23Q/Q Change
Revenue
76.6M
↑ 4.76%
Net Income
-38.0M
↓ 5.34%
Net Profit Margin
-49.64%
↑ 5.31%
Q2 FY23Q/Q Change
Revenue
83.8M
↑ 9.48%
Net Income
-37.5M
↓ 1.29%
Net Profit Margin
-44.76%
↑ 4.88%
Q3 FY23Q/Q Change
Revenue
85.8M
↑ 2.37%
Net Income
-36.8M
↓ 2.04%
Net Profit Margin
-42.84%
↑ 1.92%
Q4 FY23Q/Q Change
Revenue
91.6M
↑ 6.74%
Net Income
-31.9M
↓ 13.13%
Net Profit Margin
-34.86%
↑ 7.98%
Q1 FY24Q/Q Change
Revenue
95.0M
↑ 3.7%
Net Income
-30.6M
↓ 4.05%
Net Profit Margin
-32.26%
↑ 2.6%
FY19Y/Y Change
Total Assets
59.3M
↑ 3.72%
Total Liabilities
270.2M
↑ 20.2%
FY20Y/Y Change
Total Assets
158.8M
↑ 167.89%
Total Liabilities
56.9M
↓ 78.95%
FY21Y/Y Change
Total Assets
326.7M
↑ 105.76%
Total Liabilities
63.4M
↑ 11.37%
FY22Y/Y Change
Total Assets
494.5M
↑ 51.37%
Total Liabilities
77.2M
↑ 21.84%
FY23Y/Y Change
Total Assets
370.1M
↓ 25.16%
Total Liabilities
82.2M
↑ 6.53%
FY24Y/Y Change
Total Assets
371.1M
↑ 0.28%
Total Liabilities
119.6M
↑ 45.48%
Q4 FY22Q/Q Change
Total Assets
397.3M
↓ 6.74%
Total Liabilities
76.9M
↓ 0.74%
Q1 FY23Q/Q Change
Total Assets
370.1M
↓ 6.86%
Total Liabilities
82.2M
↑ 6.87%
Q2 FY23Q/Q Change
Total Assets
353.9M
↓ 4.38%
Total Liabilities
90.2M
↑ 9.73%
Q3 FY23Q/Q Change
Total Assets
340.4M
↓ 3.79%
Total Liabilities
93.4M
↑ 3.53%
Q4 FY23Q/Q Change
Total Assets
374.6M
↑ 10.05%
Total Liabilities
110.0M
↑ 17.8%
Q1 FY24Q/Q Change
Total Assets
371.1M
↓ 0.95%
Total Liabilities
119.6M
↑ 8.71%
FY19Y/Y Change
Operating Cash Flow
-2.1M
↓ 80.88%
Investing Cash Flow
-11.0M
↓ 7.87%
Financing Cash Flow
4.2M
↓ 86.6%
FY20Y/Y Change
Operating Cash Flow
826.0K
↓ 138.78%
Investing Cash Flow
-12.3M
↑ 11.77%
Financing Cash Flow
100.3M
↑ 2291.04%
FY21Y/Y Change
Operating Cash Flow
2.9M
↑ 249.88%
Investing Cash Flow
-25.1M
↑ 103.61%
Financing Cash Flow
150.7M
↑ 50.26%
FY22Y/Y Change
Operating Cash Flow
-74.7M
↓ 2685.12%
Investing Cash Flow
-65.2M
↑ 160.03%
Financing Cash Flow
235.0M
↑ 55.96%
FY23Y/Y Change
Operating Cash Flow
-90.1M
↑ 20.63%
Investing Cash Flow
-26.2M
↓ 59.83%
Financing Cash Flow
-20.8M
↓ 108.85%
Q4 FY22Q/Q Change
Operating Cash Flow
-20.7M
↑ 4.56%
Investing Cash Flow
-6.7M
↑ 14.97%
Financing Cash Flow
-3.7M
↑ 32.47%
Q1 FY23Q/Q Change
Operating Cash Flow
-15.9M
↓ 23.37%
Investing Cash Flow
-6.6M
↓ 1.92%
Financing Cash Flow
-10.4M
↑ 184.06%
Q2 FY23Q/Q Change
Operating Cash Flow
-13.7M
↓ 14.09%
Investing Cash Flow
-6.1M
↓ 7.88%
Financing Cash Flow
-7.2M
↓ 31.03%
Q3 FY23Q/Q Change
Operating Cash Flow
-9.3M
↓ 31.69%
Investing Cash Flow
-15.8M
↑ 159.83%
Financing Cash Flow
-3.0M
↓ 57.61%
Q4 FY23Q/Q Change
Operating Cash Flow
-6.3M
↓ 32.38%
Investing Cash Flow
-15.7M
↓ 0.49%
Financing Cash Flow
-2.3M
↓ 24.94%

Technicals Summary

Sell

Neutral

Buy

Phreesia, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Phreesia, Inc.
Phreesia, Inc.
0.96%
47.61%
-28.32%
-53.14%
-7.66%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Phreesia, Inc.
Phreesia, Inc.
NA
NA
NA
-1.23
-0.51
-0.22
NA
4.46
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Phreesia, Inc.
Phreesia, Inc.
Buy
$1.3B
-7.66%
NA
-38.42%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • FMR Inc

    13.83%

  • Vanguard Group Inc

    8.32%

  • BlackRock Inc

    7.64%

  • Brown Advisory Holdings Inc

    7.10%

  • Rock Springs Capital Management LP

    3.97%

  • T. Rowe Price Investment Management,Inc.

    3.26%

Corporate Announcements

  • Phreesia, Inc. Earnings

    Phreesia, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.

Organization
Phreesia, Inc.
Employees
1438
CEO
Mr. Chaim Indig
Industry
Technology Services

Discover More

FAQs